Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

US Patent 11464856 · Granted Oct 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
Anti-GDF15 antibody and a dosage regimen for the treatment of cancer2025
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2025
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)2024
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses2023
GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment wit2022